Nan Shan Life Insurance Co. Ltd. Sells 25,344 Shares of CME Group Inc. $CME

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Nan Shan Life Insurance Co. Ltd. lowered its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 47.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,556 shares of the financial services provider's stock after selling 25,344 shares during the period. Nan Shan Life Insurance Co. Ltd.'s holdings in CME Group were worth $7,576,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of CME. Wayfinding Financial LLC purchased a new stake in shares of CME Group during the 1st quarter valued at approximately $25,000. Cornerstone Planning Group LLC lifted its stake in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after buying an additional 55 shares in the last quarter. Golden State Wealth Management LLC lifted its stake in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after buying an additional 98 shares in the last quarter. Alpine Bank Wealth Management purchased a new stake in shares of CME Group during the 1st quarter valued at approximately $32,000. Finally, Financial Gravity Asset Management Inc. purchased a new stake in shares of CME Group during the 1st quarter valued at approximately $32,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on CME shares. Erste Group Bank cut shares of CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Barclays set a $298.00 price target on shares of CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Oppenheimer increased their target price on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Finally, UBS Group reiterated a "neutral" rating and issued a $305.00 target price on shares of CME Group in a research note on Thursday, July 24th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $261.93.

Insiders Place Their Bets

In other news, Director Charles P. Carey sold 500 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director owned 4,900 shares of the company's stock, valued at $1,300,215. This represents a 9.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director William R. Shepard purchased 256 shares of the firm's stock in a transaction dated Wednesday, June 25th. The stock was bought at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the acquisition, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.30% of the stock is owned by corporate insiders.

CME Group Price Performance

NASDAQ CME traded down $3.80 on Friday, hitting $269.52. The stock had a trading volume of 1,591,589 shares, compared to its average volume of 1,923,555. CME Group Inc. has a 52-week low of $206.44 and a 52-week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $97.13 billion, a price-to-earnings ratio of 26.09, a price-to-earnings-growth ratio of 4.95 and a beta of 0.44. The firm has a 50-day moving average of $275.82 and a 200-day moving average of $268.31.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the prior year, the company posted $2.56 EPS. Equities analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be issued a $1.25 dividend. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio is presently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.